佰金生命科学 01466·

毛利率 ----------------------------------------17.55%--9.01%8.54%33.72%24.71%30.97%2.75%7.46%23.51% 净利率 -----------------------------------------24.68%--9.99%34.67%-15.92%25.91%-0.06%15.86%-47.78%47.72% ROE -----------------------------------------43.11%--11.08%54.19%-7.73%18.82%-0.23%7.51%-20.45%20.22% ROA -----------------------------------------18.83%--8.69%27.52%-4.34%13.03%-0.03%4.31%-16.14%16.11% 营业收入增长率 --------------------------------------------49.69%---36.02%85.71%178.58%214.60%-41.83%220.41% 归属母公司净利润增长率 --------------------------------------------160.57%---188.90%349.47%95.32%284.22%-10480.59%10575.91% 资产负债率 ----------------------------------------56.32%--21.60%34.72%42.69%21.09%46.28%3.59%27.30%18.98% 流动比率 ----------------------------------------1.75--4.692.942.961.734.571.612.971.59 经营现金流 / 净利润 -----------------------------------------0.07---2.482.410.763.24323.81323.050.17323.64 经营现金流 / 营业收入 ----------------------------------------1.77%---24.77%26.54%-12.03%12.74%-20.78%8.75%-8.21%12.58%

营业收入 ----------------------------------------5,080.73 万--7,605.56 万49.69%4,866.00 万36.02%1.36 亿178.58%7,885.10 万41.83% 其他收入及收益 ----------------------------------------------------1,177.40 万--1,812.20 万53.92% 营业成本 ----------------------------------------------------9,357.00 万--8,263.90 万11.68% 毛利 ----------------------------------------891.46 万--685.18 万23.14%1,640.86 万139.48%4,198.60 万155.88%588.49 万85.98% 销售及分销费用 ----------------------------------------64.96 万--31.60 万51.35%110.06 万248.25%2,000.00 万1717.27%1,741.18 万12.94% 行政费用 ----------------------------------------1,200.78 万--1,422.89 万18.50%2,479.32 万74.25%307.00 万87.62%3,329.96 万984.68% 财务成本净额 ----------------------------------------355.30 万--90.08 万74.65%25.02 万72.22%63.30 万152.99%71.34 万12.71% 所得税 ------------------------------------------------1.45 万--127.80 万8710.88%38.58 万69.81% 经营利润 -----------------------------------------899.09 万--830.59 万192.38%-868.11 万204.52%-199.80 万76.98%-3,792.18 万1797.99% 应占联营及合营公司损益 ----------------------------------------------------0---2.60 万-- 除税前利润 -----------------------------------------1,253.98 万--759.51 万160.57%-773.20 万201.80%-136.50 万82.35%-3,806.31 万2688.50% 净利润 -----------------------------------------1,253.98 万--759.51 万160.57%-774.65 万201.99%-8.70 万98.88%-3,767.72 万43207.18% 归属母公司净利润 -----------------------------------------1,253.98 万--759.51 万160.57%-675.20 万188.90%-31.60 万95.32%-3,343.47 万10480.59%

现金及现金等价物 ----------------------------------------1,912.77 万--3,612.03 万88.84%3,434.37 万4.92%4,777.30 万39.10%3,806.40 万20.32% 应收账款及票据 ----------------------------------------2,594.75 万--1,138.03 万56.14%1,363.18 万19.78%2,508.80 万84.04%1,311.18 万47.74% 存货 ----------------------------------------1,944.48 万--3,905.29 万100.84%4,019.64 万2.93%7,063.70 万75.73%5,145.83 万27.15% 流动资产合计 ----------------------------------------6,451.99 万--8,655.35 万34.15%1.10 亿27.07%2.27 亿106.39%1.70 亿25.28% 总资产 ----------------------------------------6,659.12 万--8,741.06 万31.26%1.78 亿104.11%2.90 亿62.64%2.33 亿19.54% 流动负债合计 ----------------------------------------3,687.09 万--1,845.01 万49.96%3,716.31 万101.42%4,972.30 万33.80%5,706.24 万14.76% 总负债 ----------------------------------------3,750.27 万--1,887.65 万49.67%7,615.93 万303.46%1.34 亿76.34%6,373.49 万52.54% 归属母公司股东权益 ----------------------------------------2,908.85 万--6,853.41 万135.61%8,730.80 万27.39%1.39 亿59.53%1.64 亿17.40% 股东权益合计 ----------------------------------------2,908.85 万--6,853.41 万135.61%1.02 亿49.20%1.56 亿52.44%1.70 亿8.90%

经营活动现金流量净额 ----------------------------------------89.94 万---1,883.88 万2194.58%-585.36 万68.93%-2,817.12 万381.26%-647.03 万77.03% 投资活动现金流量净额 -----------------------------------------4.87 万--3,090.55 万63612.32%429.89 万86.09%-78.07 万118.16%-1,403.27 万1697.42% 融资活动现金流量净额 -----------------------------------------139.33 万--323.64 万332.28%74.25 万77.06%3,821.53 万5047.09%1,604.23 万58.02% 现金及现金等价物净增加额 -----------------------------------------54.26 万--1,530.30 万2920.50%-81.23 万105.31%926.34 万1240.43%-446.07 万148.15%